|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.349
|
|
|
|
mrna metabolic process
|
GO:0016071 |
84 |
0.236
|
|
|
|
histone h3 k4 trimethylation
|
GO:0080182 |
5 |
0.226
|
|
|
|
histone methylation
|
GO:0016571 |
71 |
0.208
|
|
|
|
mrna processing
|
GO:0006397 |
63 |
0.205
|
|
|
|
mrna splicing via spliceosome
|
GO:0000398 |
43 |
0.177
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.145
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.141
|
|
|
|
regulation of histone methylation
|
GO:0031060 |
30 |
0.124
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.115
|
|
|
|
rna splicing
|
GO:0008380 |
54 |
0.113
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.107
|
|
|
|
regulation of rna splicing
|
GO:0043484 |
37 |
0.105
|
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.089
|
|
|
|
regulation of mrna metabolic process
|
GO:1903311 |
43 |
0.082
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.081
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.075
|
|
|
|
rna processing
|
GO:0006396 |
105 |
0.069
|
|
|
|
rna splicing via transesterification reactions with bulged adenosine as nucleophile
|
GO:0000377 |
43 |
0.066
|
|
|
|
histone acetylation
|
GO:0016573 |
41 |
0.065
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.064
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.063
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.063
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.061
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.060
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.056
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.053
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.047
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.046
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.043
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.041
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.040
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.040
|
|
|
|
alternative mrna splicing via spliceosome
|
GO:0000380 |
12 |
0.037
|
|
|
|
protein methylation
|
GO:0006479 |
81 |
0.037
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.036
|
|
|
|
posttranscriptional gene silencing by rna
|
GO:0035194 |
10 |
0.036
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.035
|
|
|
|
regulation of alternative mrna splicing via spliceosome
|
GO:0000381 |
8 |
0.034
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.033
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.033
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.032
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.032
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.032
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.032
|
|
|
|
rna splicing via transesterification reactions
|
GO:0000375 |
43 |
0.031
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.031
|
|
|
|
internal protein amino acid acetylation
|
GO:0006475 |
42 |
0.031
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
57 |
0.031
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.030
|
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
74 |
0.030
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.030
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.030
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.030
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.029
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.029
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.029
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.029
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.029
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.028
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.026
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.026
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.026
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.026
|
|
|
|
regulation of mrna processing
|
GO:0050684 |
41 |
0.025
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.024
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.024
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.024
|
|
|
|
peptidyl lysine methylation
|
GO:0018022 |
29 |
0.024
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.024
|
|
|
|
regulation of chromatin organization
|
GO:1902275 |
57 |
0.024
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.024
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.023
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.023
|
|
|
|
protein alkylation
|
GO:0008213 |
81 |
0.023
|
|
|
|
peptidyl lysine acetylation
|
GO:0018394 |
45 |
0.023
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.023
|
|
|
|
regulation of mrna splicing via spliceosome
|
GO:0048024 |
32 |
0.023
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.023
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.022
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.022
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.022
|
|
|
|
regulation of histone modification
|
GO:0031056 |
56 |
0.021
|
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.021
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.021
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.021
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.021
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.021
|
|
|
|
regulation of histone h3 k4 methylation
|
GO:0051569 |
12 |
0.020
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.020
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.020
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.020
|
|
|
|
gene silencing by mirna
|
GO:0035195 |
10 |
0.020
|
|
|
|
carbohydrate biosynthetic process
|
GO:0016051 |
74 |
0.019
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.019
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.019
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.019
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.019
|
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.019
|
|
|
|
translation
|
GO:0006412 |
93 |
0.019
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.019
|
|
|
|
negative regulation of mesenchymal cell proliferation
|
GO:0072201 |
3 |
0.019
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.019
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.019
|
|
|
|
humoral immune response
|
GO:0006959 |
57 |
0.018
|
|
|
|
gene silencing by rna
|
GO:0031047 |
19 |
0.018
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.018
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.018
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.018
|
|
|
|
histone h4 k16 acetylation
|
GO:0043984 |
3 |
0.018
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.018
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.017
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.017
|
|
|
|
histone lysine methylation
|
GO:0034968 |
50 |
0.017
|
|
|
|
internal peptidyl lysine acetylation
|
GO:0018393 |
42 |
0.016
|
|
|
|
protein homotrimerization
|
GO:0070207 |
4 |
0.016
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.016
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.016
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.016
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.016
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.016
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.016
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.016
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.016
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.016
|
|
|
|
rna interference
|
GO:0016246 |
2 |
0.016
|
|
|
|
positive regulation of myeloid cell differentiation
|
GO:0045639 |
43 |
0.016
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.015
|
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.015
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.015
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.015
|
|
|
|
establishment or maintenance of cytoskeleton polarity
|
GO:0030952 |
2 |
0.015
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.015
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.015
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.015
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.015
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.015
|
|
|
|
regulation of gluconeogenesis
|
GO:0006111 |
30 |
0.015
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.015
|
|
|
|
regulation of b cell activation
|
GO:0050864 |
81 |
0.014
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.014
|
|
|
|
posttranscriptional gene silencing
|
GO:0016441 |
10 |
0.014
|
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
75 |
0.014
|
|
|
|
glucosamine containing compound metabolic process
|
GO:1901071 |
3 |
0.014
|
|
|
|
mitochondrion distribution
|
GO:0048311 |
4 |
0.014
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.014
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.014
|
|
|
|
microtubule nucleation
|
GO:0007020 |
2 |
0.014
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.014
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.014
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.013
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.013
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.013
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.013
|
|
|
|
gluconeogenesis
|
GO:0006094 |
39 |
0.013
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.013
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.013
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.013
|
|
|
|
peripheral nervous system neuron axonogenesis
|
GO:0048936 |
3 |
0.013
|
|
|
|
negative regulation of gluconeogenesis
|
GO:0045721 |
9 |
0.013
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.013
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.013
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.013
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.013
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.012
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.012
|
|
|
|
dna repair
|
GO:0006281 |
107 |
0.012
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.012
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.012
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.012
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.012
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.012
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.012
|
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
64 |
0.012
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.012
|
|
|
|
wnt signaling pathway planar cell polarity pathway
|
GO:0060071 |
27 |
0.012
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.012
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.012
|
|
|
|
interferon beta biosynthetic process
|
GO:0045350 |
4 |
0.012
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.012
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
91 |
0.012
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.012
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.012
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.012
|
|
|
|
response to retinoic acid
|
GO:0032526 |
56 |
0.012
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.012
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.012
|
|
|
|
nucleic acid phosphodiester bond hydrolysis
|
GO:0090305 |
49 |
0.012
|
|
|
|
negative regulation of multi organism process
|
GO:0043901 |
68 |
0.012
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.012
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.012
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.012
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.012
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.011
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.011
|
|
|
|
cytokine metabolic process
|
GO:0042107 |
71 |
0.011
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.011
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.011
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.011
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.011
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.011
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.011
|
|
|
|
mitotic chromosome condensation
|
GO:0007076 |
1 |
0.011
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.011
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.011
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.011
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.011
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.011
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.011
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.011
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.011
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.011
|
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.011
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.011
|
|
|
|
positive regulation of myeloid leukocyte differentiation
|
GO:0002763 |
26 |
0.011
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.011
|
|
|
|
gene silencing
|
GO:0016458 |
38 |
0.011
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.010
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.010
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.010
|
|
|
|
keratinocyte differentiation
|
GO:0030216 |
48 |
0.010
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.010
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.010
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.010
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.010
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.010
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.010
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.010
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.010
|
|